(Q68069868)
Statements
Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris (English)
U Thadani
S R Zellner
S Glasser
N Bittar
R Montoro
A B Miller
B Chaitman
P Schulman
A Stahl
1 December 1991